tirzepatide and meloxicam Heart Palpitations: Is There a Link? 3 Tirzepatide Interactions: What To

Tirzepatide has less post-marketing surveillance data than semaglutide (approved 2022 vs 2017), meaning rare adverse events may still be identified

The reverse switchfrom Zepbound to Contrave means adjusting back to a daily schedule and potentially slower results

Continuous monitoring and feedback to the healthcare team are essential for tailoring future treatments and managing any adverse effects, ensuring that the therapy remains as effective and comfortable as possible

If the goal is specifically to drink less, naltrexone tends to be the more straightforward option

The SURMOUNT-4 trial data showed that patients who stopped tirzepatide regained an average of 14% of their body weight over the following year, which is a real and significant concern for women who worked hard to lose weight before pregnancy

Food and Drug Administration (FDA), monitor for rare side effects that may not appear during clinical trials